Editorial Volume 9, Issue 8 pp 1849—1850
MMR-deficiency and BRCA2/EGFR/NTRK mutations
- 1 Department of Hematology/Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Received: August 1, 2017 Published: August 3, 2017
https://doi.org/10.18632/aging.101275How to Cite